Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LPS-induced Inflammatory and Behavioral Responses in Healthy Volunteers
NCT02529592Phase 1Completed
- Sponsor
- Karolinska Institutet
- Start
- Feb 2015
- Primary completion
- Apr 2015
- Modality
- Biologic
01
Overview
Phase 1, randomised, double-blind trial of lipopolysaccharide endotoxin, sponsored by Karolinska Institutet. Primary endpoints: Change from baseline in sickness behavior as measured using the SicknessQ at 7 hours and Change from baseline in anxiety state as measured using the STAI-State at 7 hours. Started Feb 2015; status: completed.
02
Drugs
lipopolysaccharide endotoxin
Beyond the preview
Go deeper on NCT02529592.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02529592.